Literature DB >> 2173602

Protective effects of sulfhydryl-containing angiotensin converting enzyme inhibitors against free radical injury in endothelial cells.

I T Mak1, A M Freedman, B F Dickens, W B Weglicki.   

Abstract

The effects of SH-containing (captopril, epi-captopril, and the free-SH form of zofenopril) and non-SH-containing (enalaprilat and lisinopril) angiotension converting enzyme (ACE) inhibitors on free radical injury in cultured endothelial cells were studied. When cultured endothelial cells were exposed to a superoxide and hydroxyl radical generating system (dihydroxyfumarate + Fe3(+)-ADP) for 30 min, lipid peroxidation [malondialdehyde (MDA) formation] occurred, and cellular viability (trypan blue exclusion) decreased to 41%; concomitantly, plasma membrane blebbing, assessed by scanning electron microscopy, occurred in 65% of the cells. Preincubation of the cells with each of the SH-agents before free radical addition resulted in an equipotent concentration-dependent (10-200 microM) inhibition (15-60%) of MDA formation; both losses in cellular viability and percent blebbed cells were reduced significantly (P less than 0.05) by concentrations as low as 10 microM of each SH-agent. However, neither of the non-SH agents up to 200 microM produced any major effect. When the effects on hydroxyl radical formation in the system were assessed by ESR spin-trapping with 5,5-dimethyl-1-pyrroline-N-oxide (DMPO), concentrations of 10 and 50 microM of the SH-agents reduced the intensity of the DMPO-OH adducts 20 and 50% respectively. Similar results were observed when the hydroxyl radical was generated from the Fenton-reagents (Fe2+ + H2O2), suggesting direct hydroxyl radical scavenging. Thus, these results demonstrate that the SH-containing ACE agents are capable of protecting the endothelial cells against free radical induced lipid peroxidation and cell injury; the mechanism may be due to direct hydroxyl radical scavenging.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173602     DOI: 10.1016/0006-2952(90)90250-o

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  18 in total

1.  Effect of asiatic acid on the Ang II-AT1R-NADPH oxidase-NF-κB pathway in renovascular hypertensive rats.

Authors:  Putcharawipa Maneesai; Sarawoot Bunbupha; Upa Kukongviriyapan; Laddawan Senggunprai; Veerapol Kukongviriyapan; Parichat Prachaney; Poungrat Pakdeechote
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-07-21       Impact factor: 3.000

Review 2.  An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development.

Authors:  H S Buttar
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

Review 3.  Influence of ACE inhibitors on free radicals and reperfusion injury: pharmacological curiosity or therapeutic hope?

Authors:  J McMurray; M Chopra
Journal:  Br J Clin Pharmacol       Date:  1991-04       Impact factor: 4.335

Review 4.  Cardioprotective effect of angiotensin-converting enzyme inhibitors in patients with coronary artery disease.

Authors:  R Ferrari; C Ceconi; S Curello; P Pepi; A Mazzoletti; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

5.  Inhibitory effects of fluvastatin, a new HMG-CoA reductase inhibitor, on the increase in vascular ACE activity in cholesterol-fed rabbits.

Authors:  H Mitani; T Bandoh; J Ishikawa; M Kimura; T Totsuka; S Hayashi
Journal:  Br J Pharmacol       Date:  1996-11       Impact factor: 8.739

Review 6.  Mechanisms of testicular torsion and potential protective agents.

Authors:  Ersagun Karaguzel; Mustafa Kadihasanoglu; Omer Kutlu
Journal:  Nat Rev Urol       Date:  2014-06-17       Impact factor: 14.432

7.  Differential effects of renin-angiotensin system blockade on atherogenesis in cholesterol-fed rabbits.

Authors:  J R Schuh; D J Blehm; G E Frierdich; E G McMahon; E H Blaine
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

8.  Superoxide dismutase activity of the captopril-iron complex.

Authors:  D Jay; A Cuella; E Jay
Journal:  Mol Cell Biochem       Date:  1995-05-10       Impact factor: 3.396

9.  Evaluation of pheniramine maleate and zofenopril in reducing renal damage induced by unilateral ureter obstruction. An experimental study.

Authors:  Ercan Yuvanc; Devrim Tuglu; Tunc Ozan; Ucler Kisa; Mahi Balci; Ertan Batislam; Erdal Yilmaz
Journal:  Arch Med Sci       Date:  2019-10-04       Impact factor: 3.318

10.  Effect of Zofenopril on regeneration of sciatic nerve crush injury in a rat model.

Authors:  Ali Murat Kalender; Ali Dogan; Vedat Bakan; Huseyin Yildiz; Mehmet Ata Gokalp; Mahmut Kalender
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2009-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.